4,000
Views
1
CrossRef citations to date
0
Altmetric
Licensed – Vaccines Review

Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review

ORCID Icon, , , , &
Pages 1-16 | Received 15 Jan 2021, Accepted 21 May 2021, Published online: 16 Jul 2021

References

  • Esposito S, Prada E, Lelii M, Castellazzi L. Immunization of children with secondary immunodeficiency. Hum Vaccines Immunother. 2015;11(11):2564–70. doi:10.1080/21645515.2015.1039208.
  • Weber DJ, Rutala WA. Immunization of immunocompromised persons. Immunol Allergy Clin North Am. 2003;23(4):605–34. doi:10.1016/S0889-8561(03)00100-0.
  • Feldman AG, Beaty BL, Curtis D, Juarez-Colunga E, Kempe A. Incidence of hospitalization for vaccine-preventable infections in children following solid organ transplant and associated morbidity, mortality, and costs. JAMA Pediatrics. 2019;173(3):260–68. doi:10.1001/jamapediatrics.2018.4954.
  • Government of Canada. Page 8: Canadian Immunization Guide: part 3 - Vaccination of Specific Populations. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-8-immunization-immunocompromised-persons.html . Updated 2018. [accessed 2020 Dec 15]
  • Moore DL. Immunization of the immunocompromised child: key principles. Paediatrics & Child Health. 2018;23(3):203–05. doi:10.1093/pch/pxx180.
  • Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Keyserling H, et al. Executive Summary: 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18. 2014. doi:10.1093/cid/cit816.
  • Danziger‐Isakov L, Kumar D. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):1-10. doi:10.1111/ctr.13563.
  • American Academy of Pediatrics. Immunization in special circumstances. In Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics. 2015: 68–101.
  • Banerjee S, Dissanayake PV, Abeyagunawardena AS. Vaccinations in children on immunosuppressive medications for renal disease. Pediatr Nephrol. 2016;31(9):1437–48. doi:10.1007/s00467-015-3219-y.
  • O’Donnell S, Dubé E, Tapiero B, Gagneur A, Doll MK, Quach C. Determinants of under-immunization and cumulative time spent under-immunized in a Quebec cohort. Vaccine. 2017;35(43):5924–31. doi:10.1016/j.vaccine.2017.08.072.
  • Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32. doi:10.1080/1364557032000119616.
  • MacDonald SE, Russell ML, Liu XC, Simmonds KA, Lorenzetti DL, Sharpe H, Svenson J, Svenson LW. Are we speaking the same language? An argument for the consistent use of terminology and definitions for childhood vaccination indicators. Hum Vaccines Immunother. 2019;15(3):740–47. doi:10.1080/21645515.2018.1546526.
  • The Cochrane Community. About covidence. Published 2019. https://community.cochrane.org/help/tools-and-software/covidence/about-covidence . [Accessed 2019 Jun 18]
  • Hong QN, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon M, Griffiths F, Nicolau B, et al. Mixed Methods Appraisal Tool (MMAT), Version 2018 User Guide.; 2018. http://mixedmethodsappraisaltoolpublic.pbworks.com/ . [accessed 2019 June 18]
  • The World Bank. World bank list of economies. Published. 2019. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups . [Accessed 2019 June 18]
  • European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2019. Published 2019. http://dx.publications.europa.eu/10.2900/512553. [Accessed 2020 Dec 15]
  • Centers for Disease Prevention and Control. Measles cases and outbreaks. Published 2020. https://www.cdc.gov/measles/cases-outbreaks.html . [Accessed 2020 Dec 15]
  • National Centre for Immunisation Research and Surveillance. Research to inform policy. Published 2019. http://www.ncirs.org.au/our-work/research-inform-policy . [Accessed 2020 Dec 15]
  • Centers for Disease Control and Prevention. Typhoid vaccines: What you need to know. Published 2019. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/typhoid.pdf . [Accessed 2020 Dec 15]
  • Centers for Disease Control and Prevention. Yellow fever vaccine: What you need to know. Published 2019. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/yf.pdf. [Accessed 2020 Dec 15]
  • Government of Canada. Yellow fever. Published 2019. https://www.canada.ca/en/public-health/services/diseases/yellow-fever.html. [Accessed 2020 Dec 15]
  • Government of Canada. Typhoid vaccine: Canadian immunization guide. Published 2019. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-23-typhoid-vaccine.html . [Accessed 2020 Dec 15]
  • Government of Canada. Bacille calmette-guérin (BCG) vaccine. Published 2014. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-2-bacille-calmette-guerin-vaccine.html . [Accessed 2020 Dec 15]
  • Nelson NP Chapter 4- travel-related infectious diseases - hepatitis A. Published 2020. https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/hepatitis-a. [Accessed 2020 Dec 15]
  • Wakeham K, Kavanagh K. The burden of HPV-associated anogenital cancers. Curr Oncol Rep. 2014;16(9):402. doi:10.1007/s11912-014-0402-4.
  • Centers for Disease Control and Prevention. Diarrhea: Common illness, global killer. Published 2015. https://www.cdc.gov/healthywater/pdf/global/programs/Globaldiarrhea508c.pdf . [Accessed 2020 Dec 15]
  • Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatrics. 2018;172(10):958–65. doi:10.1001/jamapediatrics.2018.1960.
  • Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 influenza season. MMWR Recomm Reports. 2019;68:3. doi:10.15585/mmwr.rr6803a1.
  • Centers for Disease Control and Prevention. Altered immunocompetence - General best practice guidelines for immunization: Best practices guidance of the advisory committee on immunization practices (ACIP). Published 2019. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html . [Accessed 2020 Dec 15]
  • Moore DL. Vaccine recommendations for children and youth for the 2018/2019 influenza season. Paediatrics & Child Health. 2018;23(8):565. doi:10.1093/pch/pxy150.
  • Ojha RP, Tota JE, Offutt-Powell TN, Klosky JL, Minniear TD, Jackson BE, Gurney JG. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. PLoS One. 2013;8(8):e70349. doi:10.1371/journal.pone.0070349.
  • Temkin SM, Seibel NL. Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers. Cancer. 2015;121(19):3395–402. doi:10.1002/cncr.29515.
  • Centers for Disease Control and Prevention. Rotavirus vaccination: what everyone should know. Published 2018. https://www.cdc.gov/vaccines/vpd/rotavirus/public/index.html . [Accessed 2020 Dec 15]
  • Suresh S, Upton J, Green M, Pham‐Huy A, Posfay‐Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, et al. Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018. Pediatr Transplant. 2019;23(7):e13571. doi:10.1111/petr.13571.
  • Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: a review. Int J Infect Dis. 2010;14(1):e2-e12. doi:10.1016/j.ijid.2009.03.010.
  • Centers for Disease Control and Prevention. Complications and treatments of sickle cell disease. Published 2019. https://www.cdc.gov/ncbddd/sicklecell/treatments.html#Infection . [Accessed 2020 Dec 15]
  • Belli AK, Dönmez C, Özcan Ö, Dere Ö, Dirgen Çaylak S, Dinç Elibol F, Yazkan C, Yilmaz N, Nazli O. Adherence to vaccination recommendations after traumatic splenic injury. Ulus Travma Ve Acil Cerrahi Derg. 2018;24(4):337–42. doi:10.5505/tjtes.2017.84584.
  • Government of Canada. Page 7: Canadian immunization guide: part 3 - vaccination of specific populations. Published 2016. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-7-immunization-persons-with-chronic-diseases.html . [Accessed 2020 Dec 15]
  • Bousvaros A, Lu Y. Immunizations in the child with inflammatory bowel disease. In Mamula P, Grossman A, Baldassano R, Kelsen J, Markowitz J, editors. Pediatric Inflammatory Bowel Diseaase. Cham, Switzerland: Springer; 2017. p. 663–68. doi:10.1007/978-3-319-49215-5_54.
  • MacDonald SE, Schopflocher DP, Golonka RP. The pot calling the kettle black: the extent and type of errors in a computerized immunization registry and by parent report. BMC Pediatr. 2014;14(1):1. doi:10.1186/1471-2431-14-1.
  • Doganis D, Tsolia M, Dana H, Bouhoutsou D, Pourtsidis A, Baka M, Varvoutsi M, Servitzoglou M, Kosmidis H. Compliance with immunization against H1N1 influenza virus among children with cancer. Pediatr Hematol Oncol. 2013;30(2):149–53. doi:10.3109/08880018.2012.753961.
  • Giannattasio A, Squeglia V, Lo VA, Russo M, Barbarino A, Carlomagno R, Guarino A. Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions. Italian Journal of Pediatrics. 2010;36(1):28. doi:10.1186/1824-7288-36-28.
  • Camerino M, Jackson S, Chinnakotla S, Verghese P. Effects of the influenza vaccine on pediatric kidney transplant outcomes. Pediatr Transplant. 2019;23(2):e13354. doi:10.1111/petr.13354.
  • Fernández-Prada M, Rodríguez-Martínez M, García-García R, García-Corte MD, Martínez-Ortega C. Adapting immunisation schedules for children undergoing chemotherapy. Enferm Infecc Microbiol Clin. 2018;36(2):78–83. doi:10.1016/j.eimc.2016.09.003.
  • Esposito S, Marchisio P, Droghetti R, Lambertini L, Faelli N, Bosis, Tosi S, Begliatti E, Principi N. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine. 2006;24(24):5251–55. doi:10.1016/j.vaccine.2006.03.059.
  • Carthon CE, Hall RC, Maxwell PR, Crowther BR. Impact of a pharmacist-led vaccine recommendation program for pediatric kidney transplant candidates. Pediatr Transplant. 2017;21(6):e12989. doi:10.1111/petr.12989.
  • Wagner AL, Shrivastwa N, Potter RC, Lyon-callo SK, Boulton ML. Pneumococcal and meningococcal vaccination among Michigan children with sickle cell disease. J Pediatr. 2018;196:223–29. doi:10.1016/j.jpeds.2018.01.023.
  • Nero AC, Akuete K, Reeves SL, Dombkowski KJ. Pneumococcal vaccination rates in children with sickle cell disease. J Public Heal Manag Pract. 2014;20(6):587–90. doi:10.1097/PHH.0000000000000034.
  • Setse RW, Siberry GK, Moss WJ, Wheeling J, Bohannon BA, Dominguez KL. Meningococcal conjugate and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccination among HIV-infected youth. Pediatr Infect Dis J. 2016;35(5):e152–e157S. doi:10.1097/INF.0000000000001078.
  • de de la Fuente Garcia I, Coïc L, Leclerc J-M, Laverdière C, Rousseau C, Ovetchkine, Tapiéro B. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017;64(2):315–20. doi:10.1002/pbc.26187.
  • Cecinati V, Esposito S, Schicchitano B, Delvecchio GC, Amato D, Pelucchi C, Jankovic M, De Mattia, Principi N. Effectiveness of recall systems for improving influenza vaccination coverage in children with oncohematological malignancies. Hum Vaccin. 2010;6(2):194–97. doi:10.4161/hv.6.2.10253.
  • Chen C-J, Bakeera-Kitaka S, Mupere E, Kasirye P, Munube D, Idro R, Hume H, Pfeffer B, LaRussa P, Green NS, et al. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic. J Paediatr Child Health. 2019;55(7):795–801. doi:10.1111/jpc.14291.
  • Wong CI, Billett AL, Weng S, Eng K, Thakrar U, Davies KJ. A quality improvement initiative to increase and sustain influenza vaccination rates in pediatric oncology and stem cell transplant patients. Pediatr Qual Saf. 2018;3(1):e052. doi:10.1097/pq9.0000000000000052.
  • Cortina G, Ojinaga V, Zlamy M, Goner T, Riedl M, Rauchenzauner M, Entenmann A, Müller T. Vaccination status in pediatric solid-organ transplant recipients and their household members. Exp Clin Transplant. 2019;1(1):1–6. doi:10.6002/ect.2018.0184.
  • Khemani K, Steele MK, Bakshi N, Krishnamurti L, Yildirim I. Vaccination adherence in pediatric patients post-hematopoietic stem cell transplant. Blood. 2018;132(Supplement1):3406. doi:10.1182/blood-2018-99-119283.
  • Keeley NE, Cherven BO, Weinzierl E, Olson E, Thompson A, Mertens A, Haight AE. Re-Immunization Practices Among Survivors of Pediatric Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2011;17(2):S276. doi:10.1016/j.bbmt.2010.12.370.
  • Mason KK, Becton D, Mack JM. Got polio? A QI project improving vaccinations rates in off-therapy cancer patients at Arkansas Children’s Hospital. J Investig Med. 2020;68:2. doi:10.1136/jim-2020-SRM.622.
  • Crawford NW, Heath JA, Ashley D, Downie P, Buttery JP. Survivors of childhood cancer: an Australian audit of vaccination status after treatment. Pediatr Blood Cancer. 2010;54(1):128–33. doi:10.1002/pbc.22256.
  • Patel SR, Bate J, Mathews R, Chisholm J, Heath PT. Vaccination status of children with cancer after completion of standard-dose chemotherapy and after haematopoietic stem cell transplant. Pediatr Blood Cancer. 2012;59(6):1116. doi:10.1002/pbc.
  • Volc SM, Almeida MTA, Abadi MD, Cornacchioni AL, Filho VO, Cristofani LM. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia. J Pediatr (Rio J). 2006;82(6):481–84. doi:10.2223/JPED.1532.
  • Marshall HS, McIntyref P, Richmond P, Buttery JP, Royle JA, Gold MS, Wood N, Elliott EJ, Zurynski Y, Toi CS, et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatr Infect Dis J. 2013;32(5):530–37. doi:10.1097/INF.0b013e31827e92b7.
  • Pettke A, Jocham S, Wiener A, Löcken A, Groenefeld J, Ahlmann M, Groll AH. Vaccination against influenza at a European pediatric cancer center: immunization rates and attitudes among staff, patients, and their families. Support Care Cancer. 2017;25(12):3815–22. doi:10.1007/s00520-017-3813-6.
  • Tishler D, Escobedo E, Alhushki W, Margol AS, Mehta B, Rushing T. Influenza vaccine immunization in a pediatric oncology ambulatory practice. J Clin Oncol. 2013;31(31_suppl):139. doi:10.1200/jco.2013.31.31_suppl.139.
  • Freedman JL, Reilly AF, Powell SC, Bailey LC. Quality improvement initiative to increase influenza vaccination in pediatric cancer patients. Pediatrics. 2015;135(2):e540–e546. doi:10.1542/peds.2014-0943.
  • Olshefski RS, Bibart M, Frost R, Wood E, Hampl J, Mangum R, Ardura M, Guinipero T, Cripe TP. A multiyear quality improvement project to increase influenza vaccination in a pediatric oncology population undergoing active therapy. Pediatr Blood Cancer. 2018;65(9):e27268. doi:10.1002/pbc.27268.
  • Castellino SM, Allen KE, Pleasant K, Keyes G, Poehling KA, Tooze JA. Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer. J Cancer Surviv. 2019;13(5):730–38. doi:10.1007/s11764-019-00791-9.
  • Klosky JL, Hudson MM, Chen Y, Connelly JA, Wasilewski-Masker K, Sun C-L, Francisco L, Gustafson L, Russell KM, Sabbatini G, et al. Human papillomavirus vaccination rates in young cancer survivors. J Clin Oncol. 2017;35(31):3582–90. doi:10.1200/JCO.2017.74.1843.
  • Klosky JL, Russell KM, Canavera KE, Gammel HL, Foster RH, Parra GR, Simmons JL, Green DM, Hudson MM, et al. Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer. Cancer Prev Res. 2013;6(10):1101–10. doi:10.1158/1940-6207.CAPR-13-0127.
  • Klosky JL, Russell KM, Simmons JL, Foster RH, Peck K, Green DM, Hudson MM. Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer. Pediatr Blood Cancer. 2015;62(9):1630–36. doi:10.1002/pbc.25539.
  • Höcker B, Aguilar M, SchniHodgestzler P, Pape L, Webb NJA, Bald M, Genc G, Billing H, König J, et al. Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation. Pediatr Nephrol. 2018;33(2):341–50. doi:10.1007/s00467-017-3776-3.
  • McGhee W, McHugh C, Mazariegos G, Squires R, Remaley L, Zetler K, Brown-Bakewell R, Green M, Michaels M. Improving immunization compliance in pediatric transplant candidates. Pediatr Transplant. 2017;21(Supplement 1):92–93. doi:10.1111/petr.12978.
  • Thall TV, Rosh JR, Schwersenz AH, Eickmeyer, Fernandez M, Benkov KJ, LeLeiko NS. Primary immunization status in infants referred for liver transplantation. Transplant Proc. 1994;26:191.
  • Island E, Pearson A, Kaufman S, Fishbein T. Vaccination status in pediatric patients referred for liver transplantation. Am J Transplant. 2013; 13(Supplement 5): 249. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=71057295 .
  • Murray J, Wollersheim S, Yazigi N, Khan K, Kaufman S, Island E. Vaccination status of pediatric liver transplant candidates. Pediatr Transplant. 2015;19:120–21.
  • Gonzalez B, Saracusa C. Barriers to vaccination of pediatric solid organ transplant candidates at a pediatric transplant center. Pediatr Transplant. 2017;21(Supplement 1):81–82. doi:10.1111/petr.12976.
  • Urschel S, Cremer S, Birnbaum J, DallaPozza R, Fuchs A, Jäger G, Schmitz C, Belohradsky BH, Netz H. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation. Transpl Int. 2009;23(6):619–27. doi:10.1111/j.1432-2277.2009.01030.x.
  • L’Huillier AG, Wildhaber BE, Belli DC, Rodriguez M, Siegrist CA, Posfay-Barbe KM. Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference center. Pediatr Transplant. 2012;16(1):50–57. doi:10.1111/j.1399-3046.2011.01600.x.
  • Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Sedaghat M, Alborzi A, Malek-Hosseini SA. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates. The Turkish Journal of Gastroenterology. 2015;25(1):26–31. doi:10.5152/tjg.2014.5139.
  • Daniels H, Saracusa C, Worley S, Gonzalez B. Measles and varicella vaccination status and evidence of immunity during solid organ pre-transplantation evaluation. Am J Transplant. 2018;18(Supplement 4):739. doi:10.17159/2078-516x/2016/v28i5a1627.
  • Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Haghighat M, Bahador A, Nikeghbalian S, Salahi H, Alborzi A, Malek-Hosseini SA, et al. Vaccination status in pediatric liver transplant candidates. Pediatr Transplant. 2009;13(7):820–22. doi:10.1111/j.1399-3046.2009.01177.x.
  • Chaves TSS, Pereira LM, Santos SDS, David-Neto E, Lopes MH. Evaluation of the vaccination status in pediatric renal transplant recipients. Pediatr Transplant. 2008;12(4):432–35. doi:10.1111/j.1399-3046.2007.00820.x.
  • Feldman AG, Sundaram SS, Beaty BL, Torres R, Curtis D, Juarez-Colunga E, Kempe A. Immunization status at the time of liver transplant in children and adolescents. JAMA. 2019;322(18):1822–24. doi:10.1001/jama.2019.14386.
  • Fela E, Rivard K, Pallotta A, Spinner M, Lepak M, Gonzalez BE. Pre-transplant vaccination adherence in pediatric solid organ transplant patients at a large academic medical center. Open Forum Infect Dis. 2018;5(suppl_1):S745–undefined. doi:10.1093/ofid/ofy210.2137.
  • Vo HD, Florescu DF, Brown CR, Chambers HE, Mercer DF, Vargas LM, Grant WJ, Langnas AN, Quiros-Tejeira RE. Invasive pneumococcal infections in pediatric liver-small bowel-pancreas transplant recipients. Pediatr Transplant. 2018;22(3):e13165. doi:10.1111/petr.13165.
  • Printza N, Farmaki E, Bosdou J, Gkogka C, Papachristou F. Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions. Hum Vaccin. 2010;6(10):819–22. doi:10.4161/hv.6.10.12846.
  • Bhagavatula M, Hawkins A, Inward C, Van Der, Van Der Voort J. Immunisation in renal transplantation –a joint audit. Arch Dis Child. 2012;97(Suppl 1):A159–A160. doi:10.1136/archdischild-2012-301885.374.
  • Peleg N, Zevit N, Shamir R, Chodick G, Levy I. Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders. Vaccine. 2015;33(1):182–86. doi:10.1016/j.vaccine.2014.10.086.
  • Britto MT, Schoettker PJ, Pandzik GM, Weiland J, Mandel KE. Improving influenza immunisation for high-risk children and adolescents. Quality and Safety in Health Care. 2007;16(5):363–68. doi:10.1136/qshc.2006.019380.
  • Freiberg AS, Singleton AC. Adequacy of vaccine documentation against encapsulated bacteria in a population of children with sickle cell disease. Blood. 2011;118(21):4853. doi:10.1182/blood.V118.21.4853.4853.
  • Gomes LMX, Reis TC, Vieira MM, de Andrade-Barbosa TL, Caldeira AP. Quality of assistance provided to children with sickle cell disease by primary healthcare services. Rev Bras Hematol Hemoter. 2011;33(4):277–82. doi:10.5581/1516-8484.20110077.
  • Rodríguez-Moldes B, Carbajo AJ, Sánchez B, Fernández M, Garí M, Fernández MC, Álvarez J, García A, Cela E. Seguimiento en Atención Primaria de los recién nacidos con enfermedad falciforme detectados en el cribado neonatal de la Comunidad de Madrid. Anales De Pediatría. 2015;82(4):222–27. doi:10.1016/j.anpedi.2014.04.007.
  • Yé D, Kouéta F, Dao L, Kaboret S, Sawadogo A. [Pediatric management of sickle cell disease: experience at the Charles de Gaulle University Children’s Hospital in Ouagadougou (Burkina Faso)]. Sante. 2008;18(2):71–75. doi:10.1684/san.2008.0113.
  • Howard-Jones M, Randall L, Bailey-Squire B, Clayton J, Jackson N. An audit of immunisation status of sickle cell patients in Coventry, UK. J Clin Pathol. 2009;62(1):42–45. doi:10.1136/jcp.2008.058982.
  • Infanti LM, Elder JJ, Franco K, Simms S, Statler VA, Raj A. Immunization adherence in children with sickle cell disease: a single-institution experience. J Pediatr Pharmacol Ther. 2020;25(1):39–46. doi:10.5863/1551-6776-25.1.39.
  • Nofal R, Lorenzana A. Immunization rates in patients with sickle cell disease: a single institution experience. Pediatr Blood Cancer. 2019;66(Supplement 2):263. doi:10.1002/pbc.27713.
  • Rhodes MM, Adkins L, Anderews T, Thornton J, Jaggi P. Meningococcal vaccination in children with sickle cell disease: who is responsible? Am J Hematol. 2012;87:E32–E33.
  • Akingbola TS, Tayo BO, Salako B, Layden JE, Hsu LL, Cooper RS, Gordeuk VR, Saraf SL. Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications. Hemoglobin. 2014;38(4):236–43. doi:10.3109/03630269.2014.927363.
  • Meier ER, Brown L, Hampton K, Bloom E, Lawson D, Hall SA. A novel sickle cell outreach program improves access to TCD screening, vaccines and hydroxyurea in a medically underserved area. Blood. 2019;134(Supplement_1):4696. doi:10.1182/blood-2019-130209.
  • Brousse V, Arnaud C, Lesprit E, Quinet B, Odièvre M-H,  Etienne-Julan M, Guillaumat C, Elana G, Belloy M, Garnier N, et al. Evaluation of outcomes and quality of care in children with sickle cell disease diagnosed by newborn screening: a real-world nation-wide study in France. J Clin Med. 2019;8(10):1594. doi:10.3390/jcm8101594.
  • Reeves SL, Jary HK, Gondhi JP, Kleyn M, Wagner AL, Dombkowski KJ. Pneumococcal vaccination coverage among children with sickle cell anemia, sickle cell trait, and normal hemoglobin. Pediatr Blood Cancer. 2018;65(10):e27282. doi:10.1002/pbc.27282.
  • Colombatti R, Montanaro M, Guasti F, Rampazzo P, Meneghetti G, Giordan M, Basso G, Sainati L. Comprehensive care for sickle cell disease immigrant patients: a reproducible model achieving high adherence to minimum standards of care. Pediatr Blood Cancer. 2012;59(7):1275–79. doi:10.1002/pbc.24110.
  • Hardie R, King L, Fraser R, Reid M. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening. Ann Trop Paediatr. 2009;29(3):197–202. doi:10.1179/027249309X12467994693851.
  • Meier ER, Janson IA, Hampton K, Bloom E, Duncan N, Roberson C, Rampersad A. Adherence to quality of care indicators and location of sickle cell care within Indiana. J Community Health. 2020;45(1):81–87. doi:10.1007/s10900-019-00721-x.
  • Sobota AE, Kavanagh PL, Adams WG, McClure E, Farrell D, Sprinz PG. Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic. Pediatr Blood Cancer. 2015;62(4):654–57. doi:10.1002/pbc.25390.
  • Colombatti R, Perrotta S, Masera N, Palazzi G, Notarangelo LD, Pusiol A, Bonetto E, De Zen L, Nocerino A, Samperi P, et al. Lessons learned from the H1N1 pandemic: the need to improve systematic vaccination in sickle cell disease children. A multi center survey in Italy. Vaccine. 2011;29(6):1126–28. doi:10.1016/j.vaccine.2010.11.089.
  • Bailey A, Bandi S. G136(P) Immunisation of HIV positive children. Arch Dis Child. 2013;98(Suppl 1):A63–A63. doi:10.1136/archdischild-2013-304107.148.
  • Setse R, Cutts F, Monze M, Ryon J, Quinn T, Griffen D, Moss W. HIV-1 infection as a risk factor for incomplete childhood immunization in Zambia. J Trop Pediatr. 2006;52(5):324–28. doi:10.1093/tropej/fmk002.
  • Dhesi A, Bandi S, Blake K, Welch S, Thompson M. Immunisation of children with HIV. Arch Dis Child. 2012;97(Suppl 1):A32. doi:10.1136/archdischild-2012-301885.82.
  • Tchidjou HK, Vescio MF, Sanou Sobze M, Souleyman A, Stefanelli P, Mbabia A, Moussa I, Gentile B, Colizzi V, Rezza G, et al. Low vaccine coverage among children born to HIV infected women in Niamey, Niger. Hum Vaccines Immunother. 2016;12(2):540–44. doi:10.1080/21645515.2015.1069451.
  • Succi RCM, Krauss MR, Harris DR, Machado DM, de Moraes-Pinto MI, Mussi-Pinhata MM, Ruz NP, Pierre RB, Kolevic L, Joao E, et al. Undervaccination of perinatally HIV-Infected and HIV-Exposed uninfected children in Latin America and the Caribbean. Pediatr Infect Dis J. 2013;32(8):845–50. doi:10.1097/INF.0b013e31828bbe68.
  • Succi RCM, Krauss MR, Harris DR, Machado DM, de Moraes-Pinto MI, Mussi-Pinhata MM, Pavia Ruz N, Pierre RB, Kolevic Roca LA, Joao E, et al. Immunity after childhood vaccinations in perinatally HIV-exposed children with and without HIV infection in Latin America. Pediatr Infect Dis J. 2018;37(4):304–09. doi:10.1097/INF.0000000000001831.
  • Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, van der Hoeven L, Liomba GN, Chiphangwi JD, Miotti PG, et al. Morbidity among Human Immunodeficiency Virus-1-Infected and -Uninfected African children. Pediatrics. 2000;106(6):e77–e77. doi:10.1542/peds.106.6.e77.
  • Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, Gesualdo F, Romano M, Giannattasio A, Guarino A, Carloni R, Borgia P, et al. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine. 2012;30(34):5172–78. doi:10.1016/j.vaccine.2011.02.099.
  • Giagnorio MG, Minicucci V, Mariano M, Romano R, Napolitano C, Manchisi M, Macchiaroli A, Vecchio AL, Raia V, Giannattasio A, et al. 177 Strategies to improve influenza vaccination coverage in at-risk children: the experience of patients with cystic fibrosis. J Cyst Fibros. 2013;12(Supplement 1):S93. doi:10.1016/s1569-1993(13)60318-5.
  • Welzel T, Zumbrunn T, Bonhoeffer J, Cannizzaro Schneider E, Hofer M, Kaiser D, Hentgen V, Woerner A. High vaccine coverage rates are not enough: vaccination delay and risk for vaccinepreventable diseases in pediatric patients with rheumatic diseases with and without immunosuppressive therapy. Swiss Med Wkly. 2018;184(Supplement 228):6S.
  • Nicol S, Lawrence S, Jacobson K. Inadequate vaccination uptake in children receiving anti-TNF therapy for inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2017;64(Supplement 1):501. doi:10.1097/01.mpg.0000516381.25680.b4.
  • Franczak-Chmura P, Tomaszek MB, Sobiesiak A, Opoka-Winiarska V. The vaccination status of patients with juvenile idiopathic arthritis. Pediatr Rheumatol. 2018;16(Supplement 2):128. doi:10.1186/s12969-018-0265-6.
  • Sousa H, Carvalho S, Rodrigues M, Brito I, Reis P, Rocha T, Ramos M, Santos M, Ramos F, Cabral M, Guedes M. Vaccination coverage in Portuguese children with rheumatic diseases undergoing immunosuppressive therapy. Pediatr Rheumatol. 2018;16(Supplement 2):196–97. doi:10.1002/art.40466.
  • Martinelli M, Giugliano FP,  Miele E, Strisciuglio C, Urbonas V, Serban DE, Banaszkiewicz A, Assa A, Hojsak I, Lerchova T, et al. Vaccinations and immunization status in pediatric inflammatory bowel disease: a multicenter study from the pediatric IBD porto group of the ESPGHAN. Inflamm Bowel Dis. 2020;26(9):1407–14. doi:10.1093/ibd/izz264.
  • Cagol L, Seitel T, Ehrenberg S, Frivolt K, Krahl A, Lainka E, Gerner P, Lenhartz H, Vermehren J, Radke M, et al. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine. 2020;38(7):1810–17. doi:10.1016/j.vaccine.2019.12.024.
  • Feldon M, Furnier A, Lehmann C, Fletcher B, Kues J, Speer B, Kramer S, Morgan P, Siegle L, Brady R, et al. Improving pneumococcal immunization rates among immunocompromised adolescent patients at a tertiary care children’s hospital. Arthritis Rheumatol. 67(Supplement10):2015. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=72094916 .
  • Temtem T, Whitworth J, Bagga B. Pneumococcal polysaccharide vaccination in pediatric inflammatory bowel disease. Glob Pediatr Heal. 2019;6(1):1–4. doi:10.1177/2333794x19849754.
  • Ayers M, Mahajan L, Anani A, Collyer E. Immunization rates for PPSV23 (pneumovax) in immunocompromised pediatric patients with inflammatory bowel disease: room for improvement. J Pediatr Gastroenterol Nutr. 2016;63:S76.
  • Banaszkiewicz A, Klincewicz B, Lazowska-Przeorek I, Grzybowska-Chlebowczyk U, Kąkol P, Mytyk A, Kofla A, Radzikowski A. Influenza vaccination coverage in children with inflammatory bowel disease. Influenza Other Respi Viruses. 2014;8(4):431–35. doi:10.1111/irv.12236.
  • Taylor J, Haddix EF, Badinghaus K, Burns M, Moore T, Ranz J, Anneken A, Fiorini P, Spiegel E, Morgan-Dewitt E, et al. Participation in hospital influenza collaborative is influential in improving vaccination rates in patients with juvenile idiopathic arthritis and systemic lupus erythematosus. Arthritis Rheum. 2011;63(Supplement 10):S616.
  • Spijkerman R, Teuben MPJ, Hietbrink F, Kramer WLM, Leenen LPH. A cohort study to evaluate infection prevention protocol in pediatric trauma patients with blunt splenic injury in a Dutch level 1 trauma center. Patient Prefer Adherence. 2018;12:1607–17. doi:10.2147/PPA.S169072.
  • Khasawneh MA, Contreras-Peraza N, Hernandez MC, Lohse C, Jenkins DH, Zielinski MD. Outcomes after splenectomy in children: a 48-year population-based study. Pediatr Surg Int. 2019;35(5):575–82. doi:10.1007/s00383-019-04439-8.
  • Kind EA, Craft C, Fowles JB, McCoy CE. Pneumococcal vaccine administration associated with splenectomy: missed opportunities. Am J Infect Control. 1998;26(4):418–22. doi:10.1016/S0196-6553(98)70038-0.
  • Berkhout A, Varghese V, Prasad V, Heussler H, Preece K, Clark J, Wen S. Optimising immunisations in children with 22Q11 microdeletion. J Paediatr Child Health. 2019;55(S2):15–15. doi:10.1111/jpc.14468.
  • Tennis P, Toback SL, Andrews EB, McQuay LJ, Ambrose CS. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season. Vaccine. 2012;30(42):6099–102. doi:10.1016/j.vaccine.2012.07.031.
  • Rajaram S, Steffey A, Blak B, Hickman M, Christensen H, Caspard H. Uptake of childhood influenza vaccine from 2012–2013 to 2014–2015 in the UK and the implications for high-risk children: a retrospective observational cohort study. BMJ Open. 2016;6(8):e010625. doi:10.1136/bmjopen-2015-010625.
  • Sammon CJ, McGrogan A, Snowball J, De Vries CS. Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the general practice research database. Vaccine. 2012;30(14):2483–89. doi:10.1016/j.vaccine.2011.11.077.